Showing results (491-500 of 645) with videos related to

Sort By:
Pageof 65
International Journal of Environmental Research and Public Health|October 16, 2012
Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11Rashmi Kanagal-Shamanna, Weiqiang Zhao, Saroj Vadhan-Raj, et al.
Journal of Neurology|July 15, 2009
Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force controlKim C Stewart, Hubert H Fernandez, Michael S Okun, et al.
The International Journal of Neuroscience|January 20, 2011
The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystoniasRaymond L Rosales, Mary Mildred Delgado-Delos Santos, Arlene R Ng, et al.
Movement Disorders Clinical Practice|February 24, 2023
A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's DiseaseRachel N Schade, Utaka Springer, Ania Mikos, et al.
Archives of Internal Medicine|March 1, 1988
Pregnancy and paroxysmal nocturnal hemoglobinuriaP Solal-Céligny, G Tertian, H Fernandez, et al.
Journal of Neurosurgery|June 23, 2018
Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson's diseaseLeonardo A Frizon, Sean J Nagel, Francis J May, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 22, 2017
The Safety and Efficacy of Using the O-Arm Intraoperative Imaging System for Deep Brain Stimulation Lead ImplantationLeonardo A Frizon, Jianning Shao, Andres L Maldonado-Naranjo, et al.
Parkinsonism & Related Disorders|March 8, 2008
A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disordersMichael S Okun, Ramon L Rodriguez, Kelly D Foote, et al.
Pageof 65